Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System

被引:48
|
作者
Lochhead, Jeffrey J. [1 ]
Ronaldson, Patrick T. [1 ]
Davis, Thomas P. [1 ]
机构
[1] Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA
来源
AAPS JOURNAL | 2017年 / 19卷 / 04期
关键词
blood-brain barrier; drug delivery; hypoxia; pain; tight junctions; OCCLUDIN OLIGOMERIC ASSEMBLIES; CORTICAL SPREADING DEPRESSION; SPINAL CORD BARRIER; LAMBDA-CARRAGEENAN; PROTEIN EXPRESSION; ABC TRANSPORTERS; BINDING PARTNERS; P-GLYCOPROTEIN; PERMEABILITY; CNS;
D O I
10.1208/s12248-017-0076-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A functional blood-brain barrier (BBB) is necessary to maintain central nervous system (CNS) homeostasis. Many diseases affecting the CNS, however, alter the functional integrity of the BBB. It has been shown that various diseases and physiological stressors can impact the BBB's ability to selectively restrict passage of substances from the blood to the brain. Modifications of the BBB's permeability properties can potentially contribute to the pathophysiology of CNS diseases and result in altered brain delivery of therapeutic agents. Hypoxia and/or inflammation are central components of a number of diseases affecting the CNS. A number of studies indicate hypoxia or inflammatory pain increase BBB paracellular permeability, induce changes in the expression and/or localization of tight junction proteins, and affect CNS drug uptake. In this review, we look at what is currently known with regard to BBB disruption following a hypoxic or inflammatory insult in vivo. Potential mechanisms involved in altering tight junction components at the BBB are also discussed. A more detailed understanding of the mediators involved in changing BBB functional integrity in response to hypoxia or inflammatory pain could potentially lead to new treatments for CNS diseases with hypoxic or inflammatory components. Additionally, greater insight into the mechanisms involved in TJ rearrangement at the BBB may lead to novel strategies to pharmacologically increase delivery of drugs to the CNS.
引用
收藏
页码:910 / 920
页数:11
相关论文
共 50 条
  • [21] Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases
    Rice, Olivia
    Surian, Allison
    Chen, Yupeng
    JOURNAL OF TISSUE ENGINEERING, 2022, 13
  • [22] Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system
    McDannold, Nathan
    Zhang, Yongzhi
    Power, Chanikarn
    Arvanitis, Costas D.
    Vykhodtseva, Natalia
    Livingstone, Margaret
    MICRO- AND NANOTECHNOLOGY SENSORS, SYSTEMS, AND APPLICATIONS VII, 2015, 9467
  • [23] Pain and the blood-brain barrier: obstacles to drug delivery
    Wolka, AM
    Huber, JD
    Davis, TP
    ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (08) : 987 - 1006
  • [24] Drug delivery and in vitro models of the blood-brain barrier
    Cucullo, L
    Aumayr, B
    Rapp, E
    Janigro, D
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (01) : 89 - 99
  • [25] The blood-brain barrier: Physiology and strategies for drug delivery
    Pandit, Rucha
    Chen, Liyu
    Gotz, Jurgen
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 165-166 (165-166) : 1 - 14
  • [26] Computational Nanoscopy of Tight Junctions at the Blood-Brain Barrier Interface
    Rajagopal, Nandhini
    Irudayanathan, Flaviyan Jerome
    Nangia, Shikha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [27] Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection
    Abdullahi, Wazir
    Tripathi, Dinesh
    Ronaldson, Patrick T.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2018, 315 (03): : C343 - C356
  • [28] Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease
    Liu, Xi
    Shen, Ling
    Han, Bing
    Yao, Honghong
    NON-CODING RNA RESEARCH, 2021, 6 (03): : 130 - 138
  • [29] An Overview on the Physiopathology of the Blood-Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
    Susa, Francesca
    Arpicco, Silvia
    Pirri, Candido Fabrizio
    Limongi, Tania
    PHARMACEUTICS, 2024, 16 (07)
  • [30] Drug delivery across the blood-brain barrier
    Hartz, AMS
    Bauer, B
    Baehr, CH
    Miller, DS
    Fricker, G
    CURRENT NANOSCIENCE, 2005, 1 (03) : 203 - 209